文献速递中医内科中药与中成药合理使用

小檗碱治疗糖尿病及其并发症的有益作用

Beneficial effects of berberine in the treatment of diabetes and its complications.
PubMed 文献 · Front Pharmacol · 2026-01-29

小檗碱是黄连的主要活性成分,本综述系统梳理其分离提取纯化技术、分子药理机制及新型递送技术进展,汇总证据显示小檗碱通过多层次机制改善胰岛素抵抗和全身炎症发挥抗糖尿病作用,临床试验证实其单药治疗可使2型糖尿病患者糖化血红蛋白降低1.5%,与二甲双胍相当。

要点

  • 小檗碱单药治疗2型糖尿病可降低糖化血红蛋白1.5%,与二甲双胍相当。
  • 小檗碱通过改善胰岛素抵抗和全身炎症等多层次机制发挥抗糖尿病作用。
  • 新型递送技术结合多靶点药理有望推动小檗碱成为下一代多靶点糖尿病治疗平台。

核心结论

  • 小檗碱通过多层次机制改善胰岛素抵抗和全身炎症,发挥抗糖尿病作用。
  • 临床试验证实小檗碱单药治疗可使2型糖尿病患者糖化血红蛋白降低1.5%,与二甲双胍相当。

研究设计与样本

  • 综述系统梳理小檗碱的现代分离、提取与纯化技术、分子药理机制及新型递送技术进展。

主要发现

  • 小檗碱的抗糖尿病效应汇聚于改善胰岛素抵抗和全身炎症的多层次机制。
  • 临床试验证实小檗碱单药治疗降低2型糖尿病患者糖化血红蛋白1.5%,与二甲双胍相当。

关键数值与推荐

  • 临床试验证实小檗碱单药治疗使2型糖尿病患者糖化血红蛋白降低1.5%,与二甲双胍相当。

临床怎么用

  • 小檗碱可作为2型糖尿病治疗选择,其疗效与二甲双胍相当。
  • 结合新型递送技术可优化小檗碱的临床应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Coptis chinensis (Huanglian), a key component in numerous classical Chinese herbal formulas, is traditionally applied for treating metabolic diseases based on its activity including clear heat, dry dampness, purge fire, and detoxify. Berberine (BBR), one key active component from Coptis chinensis, was contained in numerous classical Chinese herbal formulas for improving insulin resistance and regulating blood glucose levels, making them applicable for diabetes mellitus (DM) treatment. Clinical trials confirm that BBR monotherapy reduces glycated hemoglobin (HbA1c) by 1.5% in T2DM patients comparable to metformin. This review aims to explore its applications and current research progress in DM therapy. This article systematically reviews the modern separation, extraction, and purification techniques for BBR, its molecular pharmacological mechanisms, and advances in novel delivery technologies for diabetes treatment. This review synthesizes evidence that BBR exerts its anti-diabetic effects through multi-tiered mechanisms converging on the amelioration of insulin resistance and systemic inflammation. The findings provide a theoretical foundation for optimizing BBR's clinical application and promote the transformation of traditional Chinese medicine from empirical usage to a scientific and standardized therapeutic paradigm. By integrating BBR's multi-target pharmacology with cutting-edge delivery technologies, this review provides a transformative perspective, positioning BBR not merely as a natural product but as a scaffold for the rational development of next-generation, multi-target diabetes therapeutics.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Liu S, Shen J, Xu F, et al. Beneficial effects of berberine in the treatment of diabetes and its complications. Front Pharmacol. 2026. PMID: 41695989. doi:10.3389/fphar.2025.1701513

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。